ARTICLE | Clinical News
Halaven eribulin mesylate regulatory update
January 13, 2014 8:00 AM UTC
Eisai said the Czech Republic and Ireland granted reimbursement for Halaven eribulin to treat metastatic breast cancer. The synthetic analog of halichondrin B is approved to treat locally advanced or ...